The drug delivery succinic acid derivatives market is projected to grow from USD 2.0 billion in 2026 to USD 4.9 billion by 2036, at a CAGR of 9.4%. Succinic Acid Esters will dominate with a 34.0% market share, while oncology will lead the therapeutic area segment with a 39.0% share.